Page 2 - Abbott Alinity News Today

Alinity i TBI lab test measures complementary biomarkers in blood plasma and serum that are tightly correlated to brain injury when elevated.

The FDA has cleared Alinity i TBI lab test to aid in the evaluation of adults with suspected mild traumatic brain injury.

Abbott (NYSE:ABT) received FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test.

The FDA has cleared Alinity i TBI lab test to aid in the evaluation of adults with suspected mild traumatic brain injury.

06.10.2022 - MSwab & PROCEEDxFLOQ Supporting Self-Collection for HPV Screening ProgramsMISSISSAUGA, Ontario, Oct. 06, 2022 (GLOBE NEWSWIRE) - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix), a life sciences innovator, manufacturer, and exporter, ... Seite 1

With the HBsAg Next Qualitative Solution, laboratories can now better detect, analyze the infection and reduce the risks of undetected virus, have a consistent detection of all HBV genotypes and...

The test runs on Abbott's PCR-based Alinity m instrument and can detect four sexually transmitted infections simultaneously.

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections.

The test runs on Abbott's PCR-based Alinity m instrument and can detect four sexually transmitted infections simultaneously.

Researchers illustrated that vitamin D status and age influence antibody response following the initial dose of coronavirus disease 2019 vaccination.